azd-2066

Small moleculeexperimental

Clinical trial activity

10 trials · 7 clinical orgs · 0 marketing orgs

Phase 1
7
Phase 2
4
Phase 3
0
Phase 4
0

Earliest trial started Jan 1, 2008 (NCT00684502)

Timeline

2000s

  1. Jan 1, 2008

    Earliest Phase 1 Sponsor(trial)

  2. Jan 1, 2009

    Earliest Phase 2 Sponsor(trial)

Indications

Mechanism of action

Chemistry & pharmacology

Loading structure…

SMILES

C[C@@H](Oc1nnc(-c2ccncc2)n1C)c1cc(-c2cccc(Cl)c2)on1
Mol. weight
381.82 g/mol
Lipinski Ro5
Pass
Rule of 3
No
Chirality
Single Stereoisomer
Inorganic
No
Polymer
No

Oral

No

Parenteral

No

Topical

No

Sources

Also known as

  • azd2066
  • azd2066
  • azd2066
  • azd-2066
  • azd-2066
  • azd-2066

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT01145755Phase 2May 1, 2010AstraZeneca, CNS Healthcare
NCT00939094Phase 2Aug 1, 2009AstraZeneca, IQVIA, Oregon Health and Science University
NCT00930306Phase 1Jun 1, 2009AstraZeneca, ICON
NCT00857623Phase 2Feb 1, 2009Albany Medical College, AstraZeneca
NCT00829088Phase 1Jan 1, 2009AstraZeneca
NCT00813306Phase 1/Phase 2 (Phase 2)Dec 1, 2008AstraZeneca
NCT00766012Phase 1Sep 1, 2008AstraZeneca, Kyushu Clinical Pharmacolgy Reasearch Clinic
NCT00690404Phase 1Apr 1, 2008AstraZeneca, IQVIA
NCT00686504Phase 1Apr 1, 2008AstraZeneca
NCT00684502Phase 1Jan 1, 2008AstraZeneca
Showing 10 of 10 trials
Page 1 / 1

Organizations

Research & Development (7)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
AstraZenecaFor profit101022008
IQVIAFor profit2022008
Albany Medical CollegeAcademic/Hospital1012009
CNS HealthcareFor profit1012010
ICONFor profit1012009
Kyushu Clinical Pharmacolgy Reasearch ClinicAcademic/Hospital1012008
Oregon Health and Science UniversityAcademic/Hospital1012009
7 organizations
Page 1 / 1